Neoadjuvant GTX chemotherapy and IMRT-based chemoradiation for borderline resectable pancreatic cancer.
about
Current therapeutic strategies for advanced pancreatic cancer: A review for cliniciansPancreatic cancer surgery: past, present, and futureManagement of borderline and locally advanced pancreatic cancer: where do we stand?Utility of PET/CT in diagnosis, staging, assessment of resectability and metabolic response of pancreatic cancerNew challenges in perioperative management of pancreatic cancerTargeting Acidity in Pancreatic Adenocarcinoma: Multispectral Optoacoustic Tomography Detects pH-Low Insertion Peptide Probes In Vivo.Accelerated fraction radiotherapy with capecitabine as neoadjuvant therapy for borderline resectable pancreatic cancer.A multi-institutional phase 2 study of neoadjuvant gemcitabine and oxaliplatin with radiation therapy in patients with pancreatic cancer.Neoadjuvant Gemcitabine Chemotherapy followed by Concurrent IMRT Simultaneous Boost Achieves High R0 Resection in Borderline Resectable Pancreatic Cancer Patients.Neoadjuvant therapy in pancreatic cancer: an emerging strategyTherapeutic options for the management of pancreatic cancer.Novel approaches in the management of pancreatic ductal adenocarcinoma: potential promises for the future.The Role of Stereotactic Body Radiation Therapy for Pancreatic Cancer: A Single-Institution Experience.Neoadjuvant therapy of pancreatic cancer: the emerging paradigm?Multidisciplinary neoadjuvant management for potentially curable pancreatic cancer.Report from the 13th annual Western canadian gastrointestinal cancer consensus conference; calgary, alberta; september 8-10, 2011.Preoperative Biliary Drainage in Cases of Borderline Resectable Pancreatic Cancer Treated with Neoadjuvant Chemotherapy and Surgery.Metabolic Activity by 18F-FDG-PET/CT Is Prognostic for Stage I and II Pancreatic CancerNeoadjuvant chemoradiotherapy for locally advanced pancreas cancer rarely leads to radiological evidence of tumour regression.Role of radiation therapy in the management of pancreatic cancer.Stereotactic body radiation therapy in pancreatic cancer: the new frontier.The role of neoadjuvant therapy in pancreatic cancer: a review.Preoperative FOLFIRINOX for borderline resectable pancreatic cancer: Is radiation necessary in the modern era of chemotherapy?Conditionally replicative adenoviral vectors for imaging the effect of chemotherapy on pancreatic cancer cells.Outcomes of a Clinical Pathway for Borderline Resectable Pancreatic Cancer.Increased neutrophil-to-lymphocyte ratio after neoadjuvant therapy is associated with worse survival after resection of borderline resectable pancreatic ductal adenocarcinoma.Importance of resectability status in neoadjuvant treatment for pancreatic cancer.Neoadjuvant Therapy of Pancreatic Cancer: Definitions and Benefits.Neoadjuvant therapy for pancreatic cancer: an ongoing debate.Accurate prediction of nodal status in preoperative patients with pancreatic ductal adenocarcinoma using next-gen nanoparticle.Neoadjuvant treatment of pancreatic adenocarcinoma: a systematic review and meta-analysis of 5520 patients.Long-term outcomes of neoadjuvant chemotherapy before chemoradiation for locally advanced pancreatic cancer.Response assessment in pancreatic ductal adenocarcinoma: role of imaging.Optimal indication of neoadjuvant chemoradiotherapy for pancreatic cancer.Selective use of endoscopic ultrasound in the evaluation of carcinomas of the pancreatic head.Pathological and clinical impact of neoadjuvant chemoradiotherapy using full-dose gemcitabine and concurrent radiation for resectable pancreatic cancer.Meta-analysis comparing upfront surgery with neoadjuvant treatment in patients with resectable or borderline resectable pancreatic cancer.
P2860
Q26767041-9FB23F01-524B-4ECA-8B7D-A6AAE4DB89B3Q26781555-373734CE-4ADD-40A3-A998-CF9C9B66BBDAQ26825414-2DACC8C7-F2C3-4F8B-A2B9-988D04E44C87Q26827392-F68126DB-3065-41F9-82CF-9039FE34D352Q28082422-3B980857-9ADE-4980-93CD-52CEA9D08D6CQ30372356-B92E8A26-1DBD-4537-A765-E53781D69B79Q30414737-345A22F0-0128-4253-AEE9-B20F18701980Q33408075-DCB28D77-9D24-47F7-95FE-141FBDE5F837Q33437515-1F1B97BB-CCF9-49E1-9869-D0A5993E8C59Q33914671-5E6EE53E-D3D2-44D7-A80D-EFF195B09776Q34093776-57CB278D-D8B9-4668-8FA8-AA445D1202E8Q35604577-7B5FDCB1-6B3B-4EA4-B8C1-59A99BB96A0BQ35695811-84ECBC95-5F41-49E7-A149-B6320EDF0047Q35776229-A77A763E-E701-4E3C-A227-51D5764284CCQ36023889-D5017C2B-8192-4894-A7D3-3F055D577866Q36416279-AA92B5CC-E481-4622-A036-1837364492E3Q36531542-B9773433-40BF-46BD-91D7-3056D48D6235Q36540475-EBE3BC19-FBF8-4D96-B108-7C77BB48852BQ37628435-1991A4C1-AB15-4940-A6BD-5A3AAE7C0E7BQ38005349-D6C912E9-17F9-4B34-811A-37F5BDD0905EQ38245676-AA7F6D34-F220-49F4-BAA2-F5404C313F4DQ38734981-1CE71E24-83D1-40D1-ABB5-93E9A85EB0D1Q38905077-43508DD0-F027-4CE8-9D53-72DEF9474435Q39151214-54B46ACA-3881-464B-8B4B-63D7B70D91FFQ40217786-FDFE8EC8-3732-4DF8-9E24-FDD5A0B5664CQ40510647-46BCBF91-50F5-4677-A2F3-ED89AED10A08Q41002447-316700C4-548E-4E3F-AC86-B2C89A6DE765Q41573034-98FDD544-1EBC-4C55-8F8B-2A4AA4574F0CQ41826893-E0C47CD8-EA2A-4249-8072-3B38828C282DQ41869715-9786E6B3-FAED-4615-B714-04146F926D27Q42374126-7ACF8132-2F1F-4E6F-97EE-ADFB6AD59055Q44650366-B4978F41-45D8-44EC-826E-171B8D49BB05Q48113453-01297716-42AA-4589-A943-5C9EC1DDC6A3Q50558607-EA364BAD-9792-42F0-8B26-A529B707676BQ50598630-59204393-B0A9-4C9B-BF0F-E2F154228841Q53153505-841B4831-EA66-4878-A43A-35FDFBE49E1AQ55634822-7D6BBDE5-EC1B-42D0-8819-550B10DB6FD2
P2860
Neoadjuvant GTX chemotherapy and IMRT-based chemoradiation for borderline resectable pancreatic cancer.
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
2011年论文
@zh
2011年论文
@zh-cn
name
Neoadjuvant GTX chemotherapy a ...... resectable pancreatic cancer.
@ast
Neoadjuvant GTX chemotherapy a ...... resectable pancreatic cancer.
@en
type
label
Neoadjuvant GTX chemotherapy a ...... resectable pancreatic cancer.
@ast
Neoadjuvant GTX chemotherapy a ...... resectable pancreatic cancer.
@en
prefLabel
Neoadjuvant GTX chemotherapy a ...... resectable pancreatic cancer.
@ast
Neoadjuvant GTX chemotherapy a ...... resectable pancreatic cancer.
@en
P2093
P2860
P356
P1476
Neoadjuvant GTX chemotherapy a ...... resectable pancreatic cancer.
@en
P2093
Barbara Centeno
Gregory Springett
James Helm
Jason Klapman
Jongphil Kim
Manish Patel
Mokenge Malafa
Pamela Hodul
Sarah Hoffe
Tiffany Valone
P2860
P304
P356
10.1002/JSO.21954
P577
2011-04-25T00:00:00Z